Dual HER2 blockade: preclinical and clinical data

The estrogen receptor and human epidermal growth factor receptor (HER) signaling pathways are the dominant drivers of cell proliferation and survival in the majority of human breast cancers. Not surprisingly, targeting these pathways provides the most effective therapies in appropriately selected pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Tejal A, Dave, Bhuvanesh, Rodriguez, Angel A, Chang, Jenny C, Perez, Edith A, Colon-Otero, Gerardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429364/
https://www.ncbi.nlm.nih.gov/pubmed/25928889
http://dx.doi.org/10.1186/s13058-014-0419-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429364/
https://www.ncbi.nlm.nih.gov/pubmed/25928889
http://dx.doi.org/10.1186/s13058-014-0419-5

Ejemplares similares